Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
Recruiting · NCT06572267 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease | Arterial Occlusive Diseases, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Phase 2 | 2026-01-23 | NCT06572267 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xijing Hospital | 177 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ling Tao | Xi'an | China | 7 |